Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China
Article in Respiratory Medicine (April 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Respiratory Medicine (April 2024)
Article in International Journal of Chronic Obstructive Pulmonary Disease (January 2024)
Article in Canadian Journal of Respiratory Critical Care and Sleep Medicine (December 2023)